In their paper on the study, published in JAMA Ophthalmology , the researchers noted that the substantially increased risk of NAION observed in patients on semaglutide appears not to be due to differences in baseline characteristics between the cohorts. They proposed the possibility that expression of the GLP-1 receptor in the human optic nerve and GLP-1 RA-induced enhanced sympathetic nervous system activity might influence optic nerve head perfusion and potentially increase the risk of NAION. Another notable finding was that the greatest risk of NAION appeared to be within the first year following the prescription of semaglutide, a temporal association that supports a potential drug-induced risk of NAION, the researchers pointed out
This level of transparency is, frankly, something we believe should be standard across the industry, but unfortunately, it isn't always
So, if the drug helps your sleep apnea because youve lost weight, you may have to continuously take it to prevent regaining the weight and reversing any sleep apnea improvements
Glutathione IV introduces a combination of rich antioxidants in the bloodstream through a vein
Sin eso, la concentracin es irrelevante